Yang Xu

Yang Xu is a researcher affiliated with the Clinic and Polyclinic for General, Visceral and Thoracic Surgery at the University Medical Center Hamburg-Eppendorf (UKE). Their work focuses on oncology, immunology, and surgical outcomes in pancreatic, colorectal, and thoracic malignancies.

• Department: General, Visceral and Thoracic Surgery
• Research Networks: Oncology Research (UCCH), Immunology, Health Services Research

Yang Xu's research explores microbiota-derived metabolites in cancer therapy, immune checkpoint modulation in liver metastasis, and radiomics for treatment response prediction. Key projects include nomogram development for metastasis risk and analysis of post-transplantation complications.

Their publications highlight collaborations with the University Cancer Center Hamburg (UCCH) and use of the SEER database for epidemiological trends. Recent studies address TIMP1's role in pleural effusion, IKK1 in kidney injury, and machine learning in MRI analysis.

Yang Xu contributes to translational research at UKE's interdisciplinary facilities, including core research labs and clinical trial networks. No formal awards or student advising details are publicly listed in the scraped data.